{
    "last_updated": "2025-12-15",
    "data_sources": [
        "ALSCAS WhatsApp Group Discussions (2021-2025)",
        "Target ALS Global Natural History Study",
        "CSIR-IGIB GOMED Program",
        "AIIMS Delhi ALS Initiatives",
        "NIMHANS Bangalore ALS Programs",
        "ProjectMinE Trans-Ancestral Genetics"
    ],
    "overview": {
        "title": "ALS Research Initiatives & Collaborations in India",
        "description": "Comprehensive overview of research collaborations, genetic testing programs, clinical initiatives, and community-driven efforts from ALSCAS WhatsApp group discussions (2021-2025)",
        "key_achievement": "India moving from ZERO ALS research infrastructure to being part of global research community"
    },
    "categories": {
        "genetic_testing_programs": [
            {
                "id": 1,
                "program_name": "CSIR-IGIB Genetic Testing Research Project",
                "status": "Active (2022-Present)",
                "lead_organization": "CSIR-IGIB (Council of Scientific & Industrial Research - Institute of Genomics & Integrative Biology)",
                "lead_researcher": "Dr. Mohammed Faruq, Principal Scientist",
                "program_type": "FREE genetic testing through Government of India's GOMED (Genomics for Rare Disease) program",
                "genes_tested": [
                    "C9orf72 (most common genetic cause - 40% of familial cases)",
                    "SOD1 (20% of familial cases)",
                    "FUS",
                    "TDP43",
                    "OPTN",
                    "VCP",
                    "TBK1"
                ],
                "participants": {
                    "first_batch_2022": "62+ PALS",
                    "november_2025_batch": "39 PALS",
                    "status": "Testing still ongoing"
                },
                "research_purpose": [
                    "Build India's first ALS genetic database",
                    "Understand genetic patterns specific to Indian population",
                    "Identify candidates for future gene-specific treatments",
                    "Contribute to global ALS genetic research"
                ],
                "how_to_participate": {
                    "step1": "Fill Google Form shared in ALSCAS group",
                    "step2": "Wait for home visit (blood collection scheduled)",
                    "step3": "Give 6ml blood sample",
                    "step4": "Results in ~3 months",
                    "cost": "FREE of cost",
                    "website": "http://gomed.igib.in/genomic-tests"
                },
                "published_research": {
                    "october_2025": "Research study published acknowledging ALSCAS contribution",
                    "presentation": "Data being presented at medical symposiums to attract pharmaceutical companies"
                },
                "what_to_expect": [
                    "Genetic test results identifying specific mutations",
                    "Eligibility for gene-specific treatments (Tofersen for SOD1, future FUS treatments)",
                    "Family genetic counseling",
                    "Contribution to India's ALS research database"
                ],
                "sources": [
                    "http://gomed.igib.in/genomic-tests",
                    "ALSCAS WhatsApp Group - Multiple messages from September 2022 onwards"
                ]
            },
            {
                "id": 2,
                "program_name": "Commercial Genetic Testing Services",
                "status": "Available",
                "providers": [
                    {
                        "name": "Medgenome",
                        "contact": "Mr. Satyendra Gupta",
                        "cost_inr": "17,000-20,000",
                        "coverage": "Pan-India sample collection",
                        "prescription": "Required from neurologist"
                    },
                    {
                        "name": "Neuberg Diagnostics",
                        "location": "Ahmedabad",
                        "cost_inr": "Similar range"
                    }
                ],
                "genes_tested": "Comprehensive ALS panel including SOD1, C9orf72, FUS, TARDBP, OPTN",
                "turnaround_time": "2-3 weeks",
                "sources": [
                    "ALSCAS WhatsApp Group discussions"
                ]
            }
        ],
        "international_collaborations": [
            {
                "id": 1,
                "collaboration_name": "Target ALS Global Collaboration",
                "status": "Active (December 2024-Present)",
                "organization": "Target ALS, New York USA",
                "ceo_contact": "Dr. Manish Raisinghani",
                "has_detailed_info": true,
                "india_partners": [
                    {
                        "institution": "NIMHANS, Bangalore",
                        "role": "Designated as base for clinical trials"
                    },
                    {
                        "institution": "AIIMS, Delhi",
                        "role": "Designated as base for clinical trials"
                    }
                ],
                "global_natural_history_project": {
                    "description": "Collecting data and biological samples from ALS patients worldwide",
                    "india_contribution": "South Asian population data",
                    "potential_discoveries": [
                        "India-specific genetic factors",
                        "Unique disease progression patterns in South Asian populations",
                        "Younger age of onset patterns",
                        "Slower disease progression in some Indian cases"
                    ]
                },
                "detailed_info": {
                    "about_target_als": "Nonprofit organization focused on accelerating research and drug development for ALS. Connects scientists, clinicians, and pharmaceutical companies worldwide.",
                    "meeting_details": {
                        "date": "December 2024",
                        "format": "Online meeting",
                        "participants": "ALSCAS team and Dr. Manish Raisinghani"
                    },
                    "global_natural_history_study": {
                        "purpose": "Collect comprehensive data and biological samples from ALS patients worldwide to understand disease patterns and progression",
                        "india_role": "Contributing South Asian population data which may reveal unique genetic and environmental factors",
                        "sample_collection": "Blood samples, saliva, disease progression tracking",
                        "expected_outcomes": [
                            "Discovery of India-specific genetic factors",
                            "Understanding younger age of onset in Indian population",
                            "Identifying protective genes in slower-progressing cases",
                            "Positioning India for future clinical trials"
                        ]
                    },
                    "annual_conference": {
                        "date": "May 2025",
                        "format": "Virtual participation for ALSCAS members",
                        "focus": "Latest advancements in ALS research, drug development updates, clinical trial opportunities"
                    },
                    "significance_for_india": [
                        "First time India included in global ALS research network",
                        "AIIMS and NIMHANS designated as clinical trial sites",
                        "Indian patients may access experimental treatments",
                        "Data from Indian population contributes to global understanding"
                    ]
                },
                "events": {
                    "may_2025": "ALSCAS members invited to Target ALS Annual Conference (virtual participation)",
                    "focus": "Latest ALS research developments"
                },
                "what_to_expect": [
                    "India becoming part of global clinical trial network",
                    "Access to international research findings",
                    "Potential for Indian patients to participate in global trials"
                ],
                "sources": [
                    "https://www.targetals.org",
                    "https://targetals.org/global-natural-history-study/",
                    "ALSCAS WhatsApp Group - Messages from December 2024, March 2025"
                ]
            },
            {
                "id": 2,
                "collaboration_name": "ProjectMinE - Trans-Ancestral Genetics (TAG)",
                "status": "Active (2022-Present)",
                "meeting_date": "September 30, 2022",
                "participants": [
                    "Dr. Ahmad (King's College London)",
                    "Dr. Mohammed Faruq (CSIR-IGIB)",
                    "Dr. Gauri Devi (India)",
                    "ALSCAS representatives"
                ],
                "goals": [
                    "Create national database of ALS patients with genetic sequencing",
                    "Present results in medical symposiums",
                    "Attract pharmaceutical and biotech companies to India",
                    "Enable India to participate in global ALS research"
                ],
                "action_items": [
                    "Medical data collection for Indian ALS patients",
                    "Finding solutions for Indian patients to access new treatments like AMX0035 (Relyvrio)",
                    "Addressing lack of clinical trial opportunities in India"
                ],
                "sources": [
                    "https://www.projectmine.com",
                    "ALSCAS WhatsApp Group - October 2022 meeting minutes"
                ]
            },
            {
                "id": 3,
                "collaboration_name": "IFNR & IAN - First ALS/MND Awareness Day in India",
                "status": "Completed (2024)",
                "organization": "Indian Federation of Neurorehabilitation (IFNR) & Indian Academy of Neurology (IAN)",
                "has_detailed_info": true,
                "event_details": {
                    "name": "India's First ALS/MND Awareness Day",
                    "organizers": [
                        "IFNR",
                        "IAN",
                        "ALSCAS"
                    ],
                    "format": "Virtual event",
                    "key_organizer": "Dr. Nirmal Surya"
                },
                "speakers": [
                    "Dr. Nirmal Surya (Eminent neurologist)",
                    "Satvinder Kaur (Medical specialist)",
                    "CALS (Caregiver sharing experiences)"
                ],
                "topics_covered": [
                    "Understanding ALS/MND",
                    "Disease management strategies",
                    "Caregiver experiences and insights",
                    "Available support resources in India"
                ],
                "detailed_info": {
                    "significance": "First ever organized ALS/MND awareness program in India at institutional level",
                    "impact": "Increased awareness among medical community and general public about ALS/MND",
                    "video_recording": "https://www.youtube.com/live/T50GFEOfUfM",
                    "key_takeaways": [
                        "Importance of early diagnosis and intervention",
                        "Multi-disciplinary care approach for ALS patients",
                        "Role of caregivers in disease management",
                        "Available resources and support systems in India"
                    ]
                },
                "sources": [
                    "https://www.youtube.com/live/T50GFEOfUfM",
                    "ALSCAS WhatsApp Group - Event announcements 2024"
                ]
            },
            {
                "id": 4,
                "collaboration_name": "International Alliance of ALS/MND Associations",
                "status": "Active Member (July 2024-Present)",
                "organization": "International Alliance of ALS/MND Associations",
                "has_detailed_info": true,
                "membership_details": {
                    "achievement_date": "July 2024",
                    "membership_type": "Full Membership",
                    "organization_name": "ALS Care and Support Foundation (ALSCAS)"
                },
                "detailed_info": {
                    "about_alliance": "Global network of ALS/MND associations working together to support patients, caregivers, and advance research worldwide",
                    "significance_for_india": [
                        "First Indian organization to receive full membership",
                        "Recognition of ALSCAS's impactful work in India",
                        "Access to global best practices and research",
                        "Platform to showcase Indian ALS community's progress"
                    ],
                    "benefits": [
                        "Networking with global ALS organizations",
                        "Access to international conferences and symposiums",
                        "Knowledge sharing on latest treatments and care protocols",
                        "Collaborative research opportunities"
                    ],
                    "congress_participation": {
                        "event": "International Alliance Congress",
                        "year": "2024",
                        "significance": "Opportunity to showcase India's ALS research and care initiatives to global medical community",
                        "acknowledgment": "Dr. Nirmal Surya facilitated ALSCAS attendance and provided continued support"
                    }
                },
                "sources": [
                    "https://www.als-mnd.org",
                    "ALSCAS WhatsApp Group - July 2024 announcement"
                ]
            },
            {
                "id": 5,
                "collaboration_name": "IHBAS - ALS Clinic & Patient Needs Study",
                "status": "In Discussion (2024-Present)",
                "organization": "Institute of Human Behaviour and Allied Sciences (IHBAS), Delhi",
                "director": "Dr. R.K. Dhamija",
                "has_detailed_info": true,
                "proposed_initiatives": [
                    {
                        "name": "ALS Clinic Establishment",
                        "status": "Proposed",
                        "description": "Dedicated ALS clinic at IHBAS for comprehensive patient care"
                    },
                    {
                        "name": "Patient Needs Assessment Study",
                        "status": "Proposed",
                        "description": "Research study to assess specific needs of ALS patients in India"
                    }
                ],
                "detailed_info": {
                    "meeting_details": {
                        "year": "2024",
                        "participants": "ALSCAS team and Dr. R.K. Dhamija (Director, IHBAS)",
                        "outcome": "Productive discussions on establishing ALS clinic and conducting patient needs study"
                    },
                    "proposed_als_clinic": {
                        "purpose": "Provide specialized, comprehensive care for ALS patients in Delhi NCR region",
                        "services": [
                            "Diagnosis and treatment",
                            "Multi-disciplinary care coordination",
                            "Physiotherapy and rehabilitation",
                            "Palliative care support"
                        ]
                    },
                    "patient_needs_study": {
                        "objective": "Understand specific challenges, needs, and gaps in care for ALS patients in India",
                        "expected_outcomes": [
                            "Data-driven insights for better care protocols",
                            "Identification of resource gaps",
                            "Policy recommendations for government support"
                        ]
                    },
                    "significance": "Both initiatives are vitally important for improving ALS care infrastructure in India"
                },
                "sources": [
                    "https://ihbas.delhigovt.nic.in",
                    "ALSCAS WhatsApp Group - 2024 meeting updates"
                ]
            },
            {
                "id": 6,
                "collaboration_name": "AKV9 (NU-9) Experimental Therapy Research",
                "status": "Research Stage - India Collaboration",
                "organization": "DRDO (Defence Research & Development Organisation)",
                "research_scientist": "Dr. Mukesh Gautam",
                "has_detailed_info": true,
                "about_akv9": {
                    "original_name": "NU-9",
                    "current_name": "AKV9",
                    "type": "Experimental neuroprotective therapy",
                    "target": "Upper motor neuron protection"
                },
                "research_background": {
                    "preclinical_results": "Showed reversal of symptoms in genetic ALS mouse models (hSOD1G93A)",
                    "unique_aspect": "Different from other drugs - aims to reverse progression, not just slow it",
                    "development_stage": "Moving from preclinical to clinical trials"
                },
                "detailed_info": {
                    "india_collaboration": {
                        "meeting_date": "March 2023",
                        "participants": "ALSCAS team and Dr. Mukesh Gautam (DRDO Research Scientist)",
                        "location": "Delhi",
                        "discussion_topics": [
                            "AKV9 research progress and timeline",
                            "Potential for India-based clinical trials",
                            "DRDO's role in ALS research",
                            "Collaboration with NEALS (Northeast ALS Consortium)"
                        ]
                    },
                    "current_status": {
                        "phase": "Animal safety studies to determine dosage",
                        "next_steps": "Clinical trials (timeline to be determined)",
                        "india_opportunity": "Potential for India to participate in or host clinical trials"
                    },
                    "significance_for_india": [
                        "First discussion of cutting-edge ALS therapy development with Indian government research organization",
                        "Potential for India to become clinical trial center for innovative treatments",
                        "DRDO interest indicates government awareness of ALS research needs"
                    ],
                    "what_to_expect": [
                        "Continued monitoring of AKV9 development",
                        "Potential clinical trial opportunities in India",
                        "Collaboration between DRDO and international ALS research community"
                    ]
                },
                "sources": [
                    "ALSCAS WhatsApp Group - March 2023 meeting notes",
                    "DRDO collaboration discussions 2022-2023"
                ]
            }
        ],
        "hospital_initiatives": [
            {
                "id": 1,
                "institution": "AIIMS Delhi",
                "status": "Active (2024-Present)",
                "key_contact": "Dr. Vishnu VY - Associate Professor, In-charge of Neuro-muscular Cell",
                "initiatives": [
                    {
                        "name": "ALS Clinic Establishment",
                        "status": "Under Discussion",
                        "description": "Dr. Vishnu supportive of dedicated ALS clinic at AIIMS",
                        "approach": "Collaborative effort between AIIMS and ALSCAS",
                        "plan": "Multi-disciplinary approach"
                    },
                    {
                        "name": "Public Awareness Programs",
                        "status": "Approved",
                        "description": "ALS awareness programs at AIIMS",
                        "requirement": "Internal approvals across departments"
                    },
                    {
                        "name": "ALS Ready Reckoner",
                        "status": "Under Review",
                        "description": "ALSCAS provided comprehensive ALS guide to AIIMS",
                        "purpose": "Expert review and validation"
                    }
                ],
                "major_event": {
                    "name": "ALS/MND Awareness Day",
                    "date": "June 25, 2025",
                    "venue": "J.L. Auditorium, AIIMS Delhi",
                    "capacity": "500 seats",
                    "speakers": [
                        "Prof. M. Srinivas (Director, AIIMS)",
                        "Dr. Vishnu VY and senior neurologists from AIIMS",
                        "20+ doctors attended"
                    ],
                    "outcomes": [
                        "First major institutional collaboration for ALS in India",
                        "Increased awareness among medical community",
                        "Commitment from AIIMS for ongoing support",
                        "Event live-streamed for wider reach"
                    ]
                },
                "rare_disease_package": {
                    "status": "In Development",
                    "description": "Ministry of Health & Family Welfare (MoHFW) tasked AIIMS to draft funding package for rare diseases without definitive treatment",
                    "alscas_contribution": "Shared economic impact study of ALS with AIIMS"
                },
                "sources": [
                    "ALSCAS WhatsApp Group - Messages from January 2025, June 2025"
                ]
            },
            {
                "id": 2,
                "institution": "NIMHANS Bangalore",
                "status": "Active (Ongoing)",
                "key_doctors": [
                    "Dr. Nalini A. (Senior neurologist, ALS specialist)",
                    "Dr. Keerthi Priya (ALS specialist)",
                    "Dr. Deepak Menon (Research trials)"
                ],
                "services": [
                    {
                        "name": "Home Visit Program",
                        "cost": "FREE",
                        "description": "Home visiting ALS specialist doctor and team for immobile patients",
                        "target": "Specifically for ALS patients",
                        "awareness": "Many members unaware of this service"
                    },
                    {
                        "name": "Clinical Studies",
                        "trials": [
                            {
                                "name": "Cyclophosphamide Trial",
                                "lead": "Dr. Deepak Menon",
                                "description": "Trials with immunosuppressant"
                            },
                            {
                                "name": "Methylcobalamin Research",
                                "dosage": "25mg injection study",
                                "status": "Phase 2 trials, not yet FDA-approved"
                            }
                        ]
                    },
                    {
                        "name": "Target ALS Collaboration",
                        "role": "Designated as base for clinical trials",
                        "participation": "Part of Global Natural History Study",
                        "activity": "Data collection for international research"
                    },
                    {
                        "name": "Comprehensive ALS Care",
                        "services": [
                            "Multi-disciplinary team approach",
                            "Physiotherapy services",
                            "Palliative care team support"
                        ]
                    }
                ],
                "challenges": [
                    "Not currently participating in trials outside India (as of November 2025)",
                    "Limited clinical trial opportunities"
                ],
                "sources": [
                    "https://www.nimhans.ac.in/neurology/",
                    "ALSCAS WhatsApp Group - Multiple messages 2022-2025"
                ]
            }
        ],
        "government_collaborations": [
            {
                "id": 1,
                "organization": "DRDO (Defence Research & Development Organisation)",
                "status": "Initiated (2022-2023)",
                "meeting_date": "March 2022",
                "duration": "45-minute meeting with high-rank DRDO officer",
                "discussion_topics": [
                    "Government approach for ALS research and drug discovery",
                    "NU-9 (later called AKV9) research adaptation for India",
                    "Guidance on approaching government for ALS research funding",
                    "Potential defense research applications for ALS"
                ],
                "follow_up": [
                    "Discussion about using genetic data for future DRDO projects",
                    "Exploring research collaborations"
                ],
                "sources": [
                    "ALSCAS WhatsApp Group - March 2022, September 2022 messages"
                ]
            }
        ],
        "treatment_access_initiatives": [
            {
                "id": 1,
                "treatment_name": "Tofersen (Qalsody) Access Initiative",
                "status": "Advocacy Stage",
                "target_mutation": "SOD1-positive patients (~2% of ALS cases)",
                "current_cost": "$15,000 per dose (~$180,000/year)",
                "india_access": {
                    "current_status": "Not available",
                    "recommendation": "ALSCAS advocating for Indian government/AIIMS/CSIR-IGIB to contact Biogen",
                    "biogen_program": "Biogen Early Access Program",
                    "program_link": "https://www.biogen.com/science-and-innovation/access-programs.html",
                    "requirement": "Major hospital (AIIMS/NIMHANS) must apply to CDSCO"
                },
                "who_needs_it": "Patients who test positive for SOD1 mutation via genetic testing",
                "sources": [
                    "https://www.biogen.com/science-and-innovation/access-programs.html",
                    "ALSCAS WhatsApp Group - Multiple messages 2023-2025"
                ]
            },
            {
                "id": 2,
                "treatment_name": "FUS Mutation Treatment Research",
                "status": "Research Stage in India (2024-2025)",
                "description": "Team in India working on treatment for FUS mutation ALS",
                "target": "Juvenile ALS cases often linked to FUS mutation",
                "current_efforts": [
                    "Reaching doctors and genetic scientists in India",
                    "Goal: Get trial medicine prepared and administered in India",
                    "Looking for more FUS-positive patients for analysis"
                ],
                "clinical_trial_opportunity": {
                    "announcement_date": "February 2025",
                    "source": "Dr. Faruq informed ALSCAS",
                    "seeking": "Patients with SOD1, FUS, or other ALS-associated gene mutations",
                    "contact": "Nitin Kapoor or Satvinder Kaur for participation"
                },
                "who_can_participate": "Patients with confirmed FUS mutation through genetic testing",
                "sources": [
                    "ALSCAS WhatsApp Group - August 2024, February 2025 messages"
                ]
            }
        ],
        "educational_initiatives": [
            {
                "id": 1,
                "initiative_name": "ALS Ready Reckoner",
                "description": "Comprehensive ALS guide created by ALSCAS",
                "distribution": [
                    "Shared with AIIMS for expert review",
                    "Available to all members"
                ],
                "content": "Covers diagnosis, care, management"
            },
            {
                "id": 2,
                "initiative_name": "Newsletter Distribution",
                "recipients": [
                    "AIIMS departments",
                    "NIMHANS",
                    "Fortis hospitals",
                    "Sir Ganga Ram Hospital"
                ],
                "purpose": "Increases awareness among medical professionals"
            },
            {
                "id": 3,
                "initiative_name": "Awareness Events",
                "events": [
                    {
                        "name": "Race for 7 Events",
                        "location": "AIIMS",
                        "frequency": "Multiple years"
                    },
                    {
                        "name": "Global ALS Awareness Day",
                        "date": "June 21",
                        "type": "Annual"
                    },
                    {
                        "name": "MND Day Events",
                        "partners": [
                            "NIMHANS",
                            "Indousrare",
                            "MND Trust"
                        ]
                    }
                ]
            }
        ]
    },
    "timeline": {
        "2021_2022": {
            "title": "Initial Research Connections",
            "events": [
                "Contact established with CSIR-IGIB",
                "First members explore genetic testing options",
                "Discussions with DRDO about ALS research"
            ]
        },
        "september_2022": {
            "title": "CSIR-IGIB Partnership Launch",
            "events": [
                "Sohil Parekh shares success with mother's genetic testing",
                "Dr. Faruq offers free testing to ALSCAS group",
                "62 PALS register for first batch",
                "Google Form created for enrollment"
            ]
        },
        "october_2022": {
            "title": "International Collaboration",
            "events": [
                "ProjectMinE-TAG Meeting with King's College London, CSIR-IGIB, Indian neurologists, ALSCAS",
                "Discussion of national ALS database",
                "Plans for international symposium presentations"
            ]
        },
        "november_2022": {
            "title": "Conference Presentation",
            "events": [
                "Dr. Faruq presents ALS genetic research at Neurology Conference",
                "Acknowledges ALSCAS collaboration",
                "Highlights India's first large-scale ALS genetic study"
            ]
        },
        "december_2024": {
            "title": "Target ALS Connection",
            "events": [
                "Met Dr. Manish Raisinghani at International Alliance for ALS/MND (Montreal)",
                "Online follow-up meeting",
                "Discussion of Global Natural History Project",
                "Invitation to May 2025 conference"
            ]
        },
        "january_2025": {
            "title": "AIIMS Partnership Begins",
            "events": [
                "In-person meeting with Dr. Vishnu VY",
                "Discussion of ALS clinic establishment",
                "Plans for public awareness programs"
            ]
        },
        "june_2025": {
            "title": "Historic AIIMS Event",
            "events": [
                "ALS/MND Awareness Day at AIIMS - 500-person capacity",
                "AIIMS Director Prof. M. Srinivas attends",
                "20+ doctors participate",
                "Live-streamed event with media coverage"
            ]
        },
        "october_2025": {
            "title": "Research Publication",
            "events": [
                "CSIR-IGIB study published",
                "Acknowledges ALSCAS participation",
                "First major genetic research paper on Indian ALS population"
            ]
        },
        "november_2025": {
            "title": "Genetic Testing Expansion",
            "events": [
                "New batch of 39 PALS enrolled",
                "Streamlined home collection process",
                "ALSCAS covers collection costs"
            ]
        }
    },
    "key_contacts": {
        "research_collaborators": [
            {
                "name": "Dr. Mohammed Faruq",
                "position": "Principal Scientist, CSIR-IGIB",
                "focus": "ALS genetic testing, GOMED program",
                "contact": "Via http://gomed.igib.in"
            },
            {
                "name": "Dr. Vishnu VY",
                "position": "Associate Professor, AIIMS Delhi",
                "focus": "Neuromuscular diseases, ALS clinic development",
                "contact": "Through AIIMS Neurology Department"
            },
            {
                "name": "Dr. Manish Raisinghani",
                "position": "CEO, Target ALS (New York)",
                "focus": "Global ALS research coordination",
                "partnership": "AIIMS, NIMHANS collaboration"
            },
            {
                "name": "Dr. Nalini A.",
                "position": "Senior Neurologist, NIMHANS Bangalore",
                "focus": "ALS specialist, clinical care",
                "contact": "Through NIMHANS Neurology OPD"
            },
            {
                "name": "Dr. Keerthi Priya",
                "position": "ALS Specialist, NIMHANS",
                "focus": "Clinical trials, patient care",
                "contact": "Through NIMHANS"
            }
        ],
        "testing_services": [
            {
                "name": "Medgenome",
                "contact": "Mr. Satyendra Gupta",
                "service": "Commercial genetic testing",
                "cost_inr": "17,000-20,000",
                "coverage": "Pan-India sample collection"
            },
            {
                "name": "CSIR-IGIB GOMED",
                "service": "Free research-based genetic testing",
                "website": "http://gomed.igib.in/genomic-tests",
                "enrollment": "Through ALSCAS Google Form"
            }
        ],
        "organizations": [
            {
                "name": "Target ALS",
                "website": "https://www.targetals.org",
                "focus": "Global research coordination",
                "annual_conference": "May each year"
            },
            {
                "name": "ProjectMinE",
                "focus": "Global genetic research",
                "partners": "King's College London, CSIR-IGIB"
            },
            {
                "name": "Biogen",
                "drug": "Tofersen (Qalsody)",
                "early_access": "https://www.biogen.com/science-and-innovation/access-programs.html"
            },
            {
                "name": "ALSCAS (ALS Care and Support Foundation)",
                "website": "Contact via WhatsApp group",
                "social_media": {
                    "linkedin": "https://www.linkedin.com/company/als-care-and-support-foundation",
                    "instagram": "https://www.instagram.com/alscasindia",
                    "twitter": "https://twitter.com/alscasindia"
                },
                "focus": "Patient support, advocacy, research collaboration in India"
            }
        ],
        "social_media_links": {
            "alscas_linkedin": "https://www.linkedin.com/company/als-care-and-support-foundation",
            "alscas_instagram": "https://www.instagram.com/alscasindia",
            "alscas_twitter": "https://twitter.com/alscasindia",
            "note": "Follow ALSCAS on social media for latest updates on research initiatives, events, and support resources"
        }
    },
    "success_stories": [
        {
            "achievement": "750+ Families Supported",
            "description": "From small discussion group to major support network. Terms like 'ALS' and 'MND' now recognized."
        },
        {
            "achievement": "First ALS Genetic Study in India",
            "description": "62+ patients in initial batch. Published research acknowledging ALSCAS. Building national genetic database."
        },
        {
            "achievement": "AIIMS Partnership",
            "description": "First institutional collaboration. Historic awareness event (June 2025). Commitment for ALS clinic. Director-level support."
        },
        {
            "achievement": "Global Recognition",
            "description": "Target ALS partnership. ProjectMinE collaboration. International Alliance for ALS/MND membership. Featured in global ALS community."
        },
        {
            "achievement": "Government Engagement",
            "description": "AIIMS tasked to draft rare disease funding package. ALSCAS input included. Economic impact study submitted."
        },
        {
            "achievement": "Research Publication",
            "description": "October 2025: First major study published. Indian ALS genetic data now in scientific literature. ALSCAS acknowledged as contributor."
        }
    ],
    "what_to_expect": {
        "immediate_1_2_years": [
            {
                "expectation": "ALS Clinic at AIIMS Delhi",
                "status": "Under discussion",
                "description": "Multi-disciplinary care, standardized treatment protocols, training hub for other hospitals"
            },
            {
                "expectation": "Genetic Testing Results",
                "timeline": "November 2025 batch results expected by February 2026",
                "benefits": "Access to gene-specific treatments if positive, family genetic counseling"
            },
            {
                "expectation": "Clinical Trial in India",
                "status": "Dr. Faruq mentioned potential trial (February 2025)",
                "target": "Possibly for FUS or SOD1 mutations",
                "significance": "Would be first ALS clinical trial in India"
            },
            {
                "expectation": "Expanded Access to Tofersen",
                "target": "SOD1-positive patients",
                "mechanism": "Through Biogen early access program",
                "requirement": "AIIMS/NIMHANS application to CDSCO"
            }
        ],
        "medium_term_2_5_years": [
            {
                "expectation": "India as Clinical Trial Hub",
                "description": "AIIMS and NIMHANS as designated sites. Target ALS partnership bearing fruit. Access to global drug trials. Indian patients eligible for experimental treatments."
            },
            {
                "expectation": "National ALS Registry",
                "description": "Comprehensive database of all Indian ALS patients. Genetic data integrated. Disease progression tracking. Research resource for drug companies."
            },
            {
                "expectation": "More Treatment Options",
                "description": "SPG302 trials in India. New gene-specific therapies. Combination treatments. Symptomatic management drugs."
            },
            {
                "expectation": "Insurance Coverage",
                "description": "Government recognition of ALS as covered condition. Private insurance including genetic disorders. Financial support for equipment/care."
            }
        ],
        "long_term_5_10_years": [
            {
                "expectation": "India-Specific Research",
                "description": "Discovery of South Asian genetic factors. Understanding younger age of onset in India. Protective genes in slower-progressing cases. Environmental factors unique to India."
            },
            {
                "expectation": "Gene Therapy in India",
                "description": "CRISPR-based treatments. Gene silencing therapies (like Tofersen but for more genes). Indigenous development of gene therapies. Affordable access through government programs."
            },
            {
                "expectation": "Network of ALS Clinics",
                "description": "Following UK model (20+ MND centers). Major cities: Delhi, Mumbai, Bangalore, Chennai, Kolkata. Standardized care protocols. Telemedicine connections."
            },
            {
                "expectation": "Cure/Disease Modification",
                "description": "Treatments that stop progression. Reversal of symptoms (like NU-9 promises). Prevention for familial cases. Precision medicine based on genetic profile."
            }
        ]
    },
    "important_notes": {
        "current_limitations": [
            "No active clinical trials in India (NIMHANS confirmed not participating in outside trials - Nov 2025)",
            "AIIMS not yet running ALS-specific trials",
            "No infrastructure for trial management",
            "Treatment access barriers - most experimental drugs not available in India"
        ],
        "realistic_expectations": [
            "Genetic testing will provide results and contribute to research",
            "May get peace of mind if negative for mutations",
            "Even if positive, treatment may not be available/affordable immediately",
            "Results take 3 months",
            "Clinical trials 2-3 years away minimum with strict eligibility criteria"
        ],
        "bottom_line": "India's ALS community is building the foundation for future breakthroughs, one patient, one test, one collaboration at a time. Cure not imminent (5-10 year horizon more realistic). Current focus: Understanding disease, preparing for trials. Participation in research helps future generations even if not current patients."
    }
}